Cyclogest 400mg

DRUG2 trials

Sponsors

Region Midtjylland

Conditions

Infertility

Phase 3

Rectally administered micronized progesterone for luteal phase support in hormone replacement therapy frozen embryo transfer (HRT-FET) cycle – non-inferiority randomized controlled trial

WithdrawnCTIS2023-504616-15-00

Region MidtjyllandInfertility

Target: 618Updated: 2023-06-27

Rectally administered micronized progesterone for luteal phase support in hormone replacement therapy frozen embryo transfer (HRT-FET) cycle – non-inferiority randomized controlled trial

RecruitingCTIS2023-504616-15-02

Region MidtjyllandInfertility

Start: 2024-05-14Target: 618Updated: 2024-04-08

Related Papers

Rectal versus vaginal progesterone administration for luteal phase support in the hormone replacement therapy frozen embryo transfer (HRT-FET) cycle: protocol for a non-inferiority randomised controlled trial

BMJ Open2024-07-01